Elabscience

CAV3 Polyclonal Antibody

Product Code:
 
E-AB-62653
Product Group:
 
Primary Antibodies
Supplier:
 
Elabscience
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Target Species:
  • Human
  • Mouse
Application:
 
Immunohistochemistry (IHC)
Shipping:
 
Ice packs
Storage:
 
Store at -20°C. Avoid freeze / thaw cycles.
1 / 2
Immunohistochemistry of paraffin-embedded Human colon using CAV3 Polyclonal Antibody at dilution of 1:200 (40x lens).
2 / 2
Immunohistochemistry of paraffin-embedded Mouse lung using CAV3 Polyclonal Antibody at dilution of 1:200 (40x lens).
❮❯

Immunohistochemistry of paraffin-embedded Human colon using CAV3 Polyclonal Antibody at dilution of 1:200 (40x lens).
Immunohistochemistry of paraffin-embedded Mouse lung using CAV3 Polyclonal Antibody at dilution of 1:200 (40x lens).

No additional charges, what you see is what you pay! *

CodeSizePrice
E-AB-62653-60uL60uL£210.00
Quantity:
E-AB-62653-120uL120uL£291.00
Quantity:
E-AB-62653-200uL200uL£431.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: China.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Abbreviation:
CAV3
Background:
This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.
Buffer:
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Concentration:
1mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:50-1:200
Immunogen:
Recombinant fusion protein of human CAV3 (NP_001225.1).
Purification method:
Affinity purification
Target Synonym:
CAV3;LGMD1C;LQT9;VIP-21;VIP21
UNIProt ID:
P56539

Documents